Biomembrane model interaction and percutaneous absorption of papaverine through rat skin: effects of cyclodextrins as penetration enhancers

J Drug Target. 2001;9(5):379-93. doi: 10.3109/10611860108998773.

Abstract

The effects of different concentrations of beta-cyclodextrin (beta-CyD), hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) and 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-CyD) on percutaneous absorption of papaverine hydrochloride (PAP) were investigated. Abdominal rat skin mounted in Franz cells was used for in vitro experiments. To evaluate CyD interaction with a bilayer structure model, dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and DPPC-Chol (8:2 mole ratio) vesicles were used. CyD vesicle interaction was evaluated by differential scanning calorimetry. Permeation through rat skin and calorimetric experiments demonstrated that at low concentrations DM-beta-CyD shows higher enhancer activity as a possible result of a perturbing action on the skin by a complexation of its lipid components, but at higher concentrations HP-beta-CyD is the most effective. By considering that HP-beta-CyD presents a very moderate destabilizing action on the skin, we conclude that a 10% aqueous solution of this macrocycle appears to be the most suitable transdermal absorption enhancer for PAP.

MeSH terms

  • Abdomen
  • Administration, Cutaneous
  • Animals
  • Circular Dichroism
  • Cyclodextrins / administration & dosage
  • Cyclodextrins / chemistry
  • Cyclodextrins / pharmacokinetics*
  • Dialysis
  • Drug Carriers / administration & dosage
  • Drug Carriers / chemistry
  • Drug Carriers / pharmacokinetics
  • In Vitro Techniques
  • Male
  • Membranes, Artificial
  • Models, Biological*
  • Papaverine / administration & dosage
  • Papaverine / chemistry
  • Papaverine / pharmacokinetics
  • Permeability / drug effects
  • Rats
  • Skin Absorption / physiology*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / chemistry
  • Vasodilator Agents / pharmacokinetics

Substances

  • Cyclodextrins
  • Drug Carriers
  • Membranes, Artificial
  • Vasodilator Agents
  • Papaverine